Reaction
Infected Fistula reporting signals
As of the last recalculation, Infected Fistula appears in 522 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is INFLIXIMAB-DYYB (PRR 44.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Infliximab-Dyyb | 31 | 44.9 | 44.9 |
| Paricalcitol | 10 | 28.8 | 28.8 |
| Teduglutide | 9 | 27.1 | 27.1 |
| Vedolizumab | 42 | 21.1 | 21.1 |
| Ustekinumab | 46 | 19.6 | 19.6 |
| Cinacalcet Hydrochloride | 7 | 6.1 | 6.1 |